Neuropathic Potential of Cabazitaxel Comparative to Paclitaxel and Ameliorative Effect of Capsaicin

Authors

  • S Pal DSKM College of Pharmacy, RKDF University, Airport Bypass Road, Gandhinagar, Bhopal, 462033, M.P., India
  • A Shukla Amity Institute of Pharmacy, Amity University Uttar Pradesh, Gomti Nagar Extension, Lucknow, Uttar Pradesh, India
  • P Bigoniya Dr Satyendra Kumar Memorial College of Pharmacy, RKDF University, Airport Bypass Road, Gandhinagar, Bhopal, Madhya Pradesh, India

DOI:

https://doi.org/10.12300/rrjopc.v5i2.138

Keywords:

Cabazitaxel, Capsaicin, Cold allodynia, Heat hyperalgesia, Paclitaxel, Neuropathy

Abstract

Paclitaxel and cabazitaxel both are the cytotoxic anticancer drugs having microtubule damaging property. The study aims at comparative neuropathic potential evaluation of cabazitaxel against paclitaxel and to assess the efficacy level of intraperitoneally applied capsaicin isolated from Capsicum annuum seed against both paclitaxel and cabazitaxel-induced neuropathy. Neuropathy was evaluated of heat hyperalgesia, cold allodynia, tactile mechanical hyperalgesia and extent of motor incoordination and motor impairment development on mice. Alternate day dosing of paclitaxel and cabazitaxel at 2 mg/kg for 14 days having cumulative dose of 16 mg/kg, showed induction of neuropathy 13th day onward. Ameliorative efficacy of capsaicin was evaluated at 0.75, 1.25 and 1.75 mg/kg, i.p. dose treated for 14 days with neuropathy assessment on 0, 7th, 14th, 21st and 28th day. Paclitaxel and cabazitaxel both showed high intensity peripheral neuropathy against heat hyperalgesia followed by tactile mechanical hyperalgesia and cold allodynia. Capsaicin showed dose-dependent reversal of both paclitaxel and cabazitaxel induced heat hyperalgesia and cold allodynia. Capsaicin 1.75 mg/kg, i.p, had maximum ameliorative effect against cold allodynia induced by paclitaxel followed by cabazitaxel. Cabazitaxel induced high intensity peripheral neuropathy against heat hyperalgesia followed by tactile mechanical hyperalgesia and cold allodynia similar to paclitaxel. Capsaicin showed intense antinociceptive effect against cold allodynia followed by tactile mechanical hyperalgesia and heat hyperalgesia. Antinociceptive effect of capsaicin was more pronounced against paclitaxel as compared to cabazitaxel-induced neuropathy.

 

Keywords: Cabazitaxel, capsaicin, cold allodynia, heat hyperalgesia, paclitaxel

Cite this Article

Pal S, Shukla A, Bigoniya P. Neuropathic potential of cabazitaxel comparative to paclitaxel and ameliorative effect of capsaicin. Research & Reviews: A Journal of Pharmacognosy. 2018; 5(2): 25–38p.

Author Biography

  • S Pal, DSKM College of Pharmacy, RKDF University, Airport Bypass Road, Gandhinagar, Bhopal, 462033, M.P., India
    Principal and Professor, DSKM College of Pharmacy, RKDF University

Downloads

Additional Files

Published

2018-10-08

Issue

Vol. 5 No. 2 (2018)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.